Literature DB >> 3944219

Effect of thiamine deficiency and its reversal on cerebral blood flow in the rat. Observations on the phenomena of hyperperfusion, "no reflow," and delayed hypoperfusion.

A M Hakim.   

Abstract

Local CBF (LCBF) was determined in the same rat model and at the same intervals of thiamine deficiency and reversal as in previous studies of local cerebral glucose utilization (LCGU) and pH (LCpH). The results showed that prior to the appearance of the clinical sequelae of thiamine deficiency (opisthotonus, which usually occurs on day 18 of deficiency) cerebral structures such as the mammillary body, vestibular nucleus, inferior colliculus, and thalamus showed significant hyperperfusion, reaching greater than 200% of control values. At opisthotonus, there was a general decline in LCBF, but, in addition, the larger of these structures developed inhomogeneous perfusion with patches of hyperperfusion adjacent to others of low flow. Seven days of thiamine replenishment at opisthotonus resulted in delayed hypoperfusion notably in the mammillary body, inferior colliculus, and thalamic nuclei. Superimposition of the LCBF, LCGU, and LCpH data reveals that structures known to be vulnerable to the development of histological lesions in this model showed an early phase of hyperperfusion uncoupled from declining LCGU and normal LCpH. Then, following a significant but only focal rise in LCGU between days 11 and 14 of deficiency, hyperperfusion persisted while the pH was dropping and LCGU was rapidly declining. The phase of patchy perfusion occurred only in the histologically vulnerable structures when LCGU was very low and acidosis was at its peak, suggesting that it may have resulted from these opposing influences on LCBF. Following replenishment with thiamine, the vulnerable structures showed delayed hypoperfusion coupled to LCGU.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3944219     DOI: 10.1038/jcbfm.1986.10

Source DB:  PubMed          Journal:  J Cereb Blood Flow Metab        ISSN: 0271-678X            Impact factor:   6.200


  9 in total

1.  Home-based behavioral treatment.

Authors:  K Pomeranz
Journal:  J Autism Dev Disord       Date:  1999-10

Review 2.  Thiamine deficiency: an update of pathophysiologic mechanisms and future therapeutic considerations.

Authors:  Eman Abdou; Alan S Hazell
Journal:  Neurochem Res       Date:  2014-10-09       Impact factor: 3.996

3.  The effect of thiamine deficiency on the structure and physiology of the rat forebrain.

Authors:  M Armstrong-James; D T Ross; F Chen; F F Ebner
Journal:  Metab Brain Dis       Date:  1988-06       Impact factor: 3.584

4.  Focal hyperemia in Wernicke's encephalopathy: a preliminary arterial spin labeling MRI study.

Authors:  Sang-Bae Ko; Tae Jung Kim; Chul-Ho Sohn
Journal:  Neuroradiology       Date:  2019-11-15       Impact factor: 2.804

5.  Depletion of brain histamine produces regionally selective protection against thiamine deficiency-induced lesions in the rat.

Authors:  Philip J Langlais; Robert Carter McRee; Julia A Nalwalk; Lindsay B Hough
Journal:  Metab Brain Dis       Date:  2002-09       Impact factor: 3.584

Review 6.  Wernicke's encephalopathy--causes to consider.

Authors:  N Heye; K Terstegge; C Sirtl; U McMonagle; K Schreiber; M Meyer-Gessner
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

7.  Region-selective permeability of the blood-brain barrier to α-aminoisobutyric acid during thiamine deficiency and following its reversal.

Authors:  Alan S Hazell; Roger F Butterworth
Journal:  Metab Brain Dis       Date:  2020-11-27       Impact factor: 3.584

8.  Thiamine deficiency activates hypoxia inducible factor-1α to facilitate pro-apoptotic responses in mouse primary astrocytes.

Authors:  Kristy Zera; Jason Zastre
Journal:  PLoS One       Date:  2017-10-18       Impact factor: 3.240

Review 9.  The Inferior Colliculus in Alcoholism and Beyond.

Authors:  Tanuja Bordia; Natalie M Zahr
Journal:  Front Syst Neurosci       Date:  2020-12-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.